Eris Lifesciences Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2007.
2007 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Eris Lifesciences Limited

Eris Lifesciences Limited, a active public limited company, was established on 25 January 2007 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24232GJ2007PLC049867. Registered under ROC Roc Ahmedabad. it is listed on BSE: 540596 and NSE: ERIS. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹13.62 Cr.

Formerly known as Eris Lifesciences Private Limited, Eris Lifescience Private Limited. It upholds a compliant status. In 2023, it reported revenue of ₹1,347.99 Cr and a net worth of ₹2,221.88 Cr. Employing 3,131 professional, Its leadership includes Krishnakumar Vaidyanathan (Whole-Time Director), Rajeev Dalal (Director), Inderjeet Singh Negi (Whole-Time Director). Past directors included Kirit Nanubhai Shelat, Vijaya Sampath, Krishnakumar Vaidyanathan. It holds ₹1,524.82 Cr open charges and ₹1,252.50 Cr settled loans. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24232GJ2007PLC049867

  • Registration Number

    049867

  • Incorporation Date

    25 January 2007

  • Authorized Capital

    ₹30.00 Cr

  • Paid-Up Capital

    ₹13.62 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed (BSE: 540596, NSE: ERIS)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 30.00 Cr
  • Paid Up Capital ₹ 13.62 Cr
  • Company Age 19 Year, 30 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 1,524.82 Cr
  • Satisfied Charges ₹ 1,252.50 Cr
  • Revenue Growth **** 8.30%
  • Profit Growth **** -4.60%
  • Ebitda **** 4.36%
  • Net Worth 15.81%
  • Total Assets **** 29.45%
Company report

Eris Lifesciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Eris Lifesciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Eris Lifesciences Limited?
Current Directors
Name Designation Appointment Date Status
Krishnakumar Vaidyanathan Whole-Time Director 20 Dec 2020 Current
Rajeev Dalal Director 19 Dec 2020 Current
Inderjeet Singh Negi Whole-Time Director 25 Jan 2007 Current
Kalpana Vasantrai Unadkat Director 05 Jan 2021 Current
Prashant Gupta Director 30 Apr 2018 Current
Amit Indubhushan Bakshi Managing Director 27 Jan 2007 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 11 Sep 2020 Past
Pramod Abcsdd Director 19 Jul 2022 Past
Pramod Abcsdd Additional Director 01 Sep 2021 Past
Pramod Abcsdd Additional Director 01 Sep 2021 Past
Pramod Abcsdd Director 03 Feb 2017 Past
Pramod Abcsdd Director 26 May 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Eris Lifesciences.

Eris Lifesciences Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.3% increase. The company also saw a slight decrease in profitability, with a 4.6% decrease in profit. The company's net worth Soared by an impressive increase of 15.81%.

Eris Lifesciences revenue growth over time
Eris Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 8.30%
*******
*******
*******
*******
Revenue from Operations
*******
 9.46%
*******
*******
*******
*******
Total Assets
*******
 29.45%
*******
*******
*******
*******
Profit or Loss
*******
 -4.60%
*******
*******
*******
*******
Net Worth
*******
 15.81%
*******
*******
*******
*******
EBITDA
*******
 4.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Eris Lifesciences?

In 2023, Eris Lifesciences had a promoter holding of 52.86% and a public holding of 47.14%. The company had 6 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,248,200,000.00

Satisfied Charges

₹12,525,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 662.00 Cr
  • Citi Bank N.A. : 525.82 Cr
  • Axis Bank Limited : 337.00 Cr
Latest Charge Details
Date Lender Amount Status
04 Apr 2025 Hdfc Bank Limited ₹150.00 Cr Open
27 Dec 2023 Hdfc Bank Limited ₹212.00 Cr Open
21 Dec 2023 Citi Bank N.A. ₹280.00 Cr Open
21 Aug 2023 Citi Bank N.A. ₹120.82 Cr Open
26 Jul 2023 Axis Bank Limited ₹337.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Eris Lifesciences?

Eris Lifesciences has a workforce of 3131 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Eris Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eris Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Eris Lifesciences
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 150.00 Cr with Charge ID 101091534 was registered on 04 Apr 2025. was documented.

  • Charges

    The activity A charge registered on 13 Feb 2024 via Charge ID 100890095 with Others was fully satisfied on 21 Feb 2025. was completed.

  • Annual General Meeting

    Progress on Eris Lifesciences Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Eris Lifesciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 437.50 Cr with Charge ID 100890095 was registered on 13 Feb 2024. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 212.00 Cr with Charge ID 100838342 was registered on 27 Dec 2023. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Eris Lifesciences Limited?

The CIN of Eris Lifesciences Limited is L24232GJ2007PLC049867.

Where is Eris Lifesciences Limited headquartered?

Eris Lifesciences Limited is headquartered at Shivarth Ambit, Plot No 142/2, Ramdas Road Off Sbr Near Swati Bungalows, Bodakdev, Ahmedabad, Gujarat, 380054.

When was Eris Lifesciences Limited incorporated?

Eris Lifesciences Limited was incorporated on 25 January 2007.

Who are the current directors of Eris Lifesciences Limited?

The current directors of Eris Lifesciences Limited are

What is the primary industry of Eris Lifesciences Limited?

The primary industry of Eris Lifesciences Limited is Manufacturing.

Is Eris Lifesciences Limited a listed company?

Eris Lifesciences Limited is listed. It is listed on BSE: 540596 and NSE: ERIS.

What is the capital structure of Eris Lifesciences Limited?

The authorized capital of Eris Lifesciences Limited is ₹30.00 Cr, and the paid-up capital is ₹13.62 Cr.

What is the compliance status of Eris Lifesciences Limited?

The compliance status of Eris Lifesciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available